Navigation Links
Illinois Pharmaceutical Manufacturer Sued for Injuries to Kentucky Resident
Date:5/14/2008

Injuries Believed to be Caused by Contaminated Blood Thinner

CHICAGO, May 14 /PRNewswire/ -- The blood thinner Heparin continues to make headlines as more people are found to have suffered serious injuries and/or death after using the contaminated drug -- a group of which appears to include many Kentucky residents. On Friday, May 2, 2008, another lawsuit was filed against Chicago-area pharmaceutical giant, Baxter International Inc. on behalf of Louisville, Kentucky resident, Artemus Banks. The complaint was filed by Nolan Law Group in Federal Court located in Chicago, Illinois. Nolan Law Group has already been responsible for filing several lawsuits on behalf of victims and the families of victims who have suffered a personal injury and/or death caused by the use of this contaminated drug. Due to the enormity and severity of the contamination, Nolan Law Group expects to file many more similar cases.

This most recent lawsuit names Scientific Protein Laboratories L.L.C. (the company which manufactures the active pharmaceutical ingredient API in Heparin) as well as certain corporate officers of Baxter. The lawsuit asserts that Baxter International and its wholly-owned subsidiary, Baxter Healthcare Corporation, manufactured the drug with a contaminated API and that Baxter failed to recall the defective drug in a timely fashion. The suit cites four causes of action against Baxter and Scientific Protein Labs including Products Liability, Negligence, Breach of Warranties and Willful and Wanton Misconduct.

Baxter's Heparin has been implicated in more than 400 life-threatening incidents and may be responsible for as many as 81 deaths. In February 2008, Baxter initiated a voluntary recall of nine lots of Heparin Sodium Injection Multi-Dose Vials. According to Baxter International, they recalled the lots due to a spike in adverse reports associated with the use of Baxter Heparin Sodium Injections. After receiving additional reports of similar ad
'/>"/>

SOURCE Nolan Law Group
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Cytochroma opens U.S. headquarters in Illinois
2. Meredith Martin Addy Named One of Top 10 Illinois Super Lawyers for 2008
3. Twenty-One Brinks Hofer Gilson & Lione Attorneys Named 2008 Illinois Super Lawyers
4. Sagent Pharmaceuticals Provides US$20,000 in Aid to Earthquake-Devastated Areas in Central China
5. Simcere Pharmaceutical Group to Participate in Upcoming Investor Conferences in New York
6. Access Pharmaceuticals to Present at the Rodman & Renshaw 5th Annual Global Healthcare Conference
7. Memory Pharmaceuticals Reports First Quarter 2008 Financial Results
8. Jazz Pharmaceuticals, Inc. Announces First Quarter 2008 Financial Results
9. Peregrine Pharmaceuticals Reports Studies Published in Science Highlight Key Role of Phosphatidylserine (PS) in Viral Infections
10. Medimetriks Pharmaceuticals, Inc. Begins Operations
11. SGX Pharmaceuticals Announces First Quarter Financial Results and Gives Pipeline Update
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)... DELHI, India, Dec. 3 /PRNewswire-Asia/ -- Dr. Susan ... Biotechnology Co. Ltd.,( http://www.beikebiotech.com ), spoke at ... Delhi, India, November 22, 2009. Beike is China,s ... The conference, organized by ...
(Date:12/2/2009)... Dec. 2 Reportlinker.com announces that a ... its catalogue: ,, Carbondioxide Incubators - ... http://www.reportlinker.com/p0164368/Carbondioxide-Incubators---A-Global-Market-Perspective.html ,, Incubators are the ... cancer, research, and other applications for providing ...
(Date:12/2/2009)... Pharmaceuticals, Inc. (Nasdaq: PPHM ) today reported completion ... trial of Cotara® in patients with relapsed glioblastoma multiforme ... is a targeted monoclonal antibody linked to a radioisotope ... Cotara specifically targets cells at the center of ...
(Date:12/2/2009)... Mass., Dec. 2 TechConnect World, an event ... product integration in cleantech, nanotech, biotech and MEMS, ... and business presentations. ,, Now in its 14th ... Science and Technology Institute (NSTI), and the Clean ...
Breaking Biology Technology:Beike Biotechnology CSO Speaks on Role of Stem Cells in Treating Diabetic Foot Disease at IPA Diabetic Foot Care Conference, India 2Beike Biotechnology CSO Speaks on Role of Stem Cells in Treating Diabetic Foot Disease at IPA Diabetic Foot Care Conference, India 3Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 2Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 3Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 4Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 2Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 3Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 4Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 5Deadline Approaching for Largest Commercialization Event for Nanotech & Clean Technologies 2Deadline Approaching for Largest Commercialization Event for Nanotech & Clean Technologies 3
... and assemble MOD® units, an innovative medication dispenser produced by Avancen ... ... 2009 -- Zeus, Inc., a global leader in the design and ... with Avancen MOD Corporation. Avancen produces the MOD (Medication on ...
... 13 On February 10, 2009, NeoStem, Inc. (NYSE ... NYSE Alternext US (the "Alternext") indicating that the Company ... Alternext Company Guide (the "Guide"), which requires a listed ... November 3, 2008, the Company had announced that it ...
... facility opening in Second Quarter,TORONTO, Feb. 13 /PRNewswire-FirstCall/ ... despite a challenging year for the biopharmaceutical industry, ... advance toward the ultimate goal of sustained profitability. ... quarter ended December 31, 2008. , In a ...
Other Biology Technology:Zeus Partners with Avancen MOD Corp. 2NeoStem Receives Notice of Noncompliance from NYSE Alternext US 2Microbix First Quarter Sales Grow Over 50% With Continued Progress On The Pipeline 2Microbix First Quarter Sales Grow Over 50% With Continued Progress On The Pipeline 3Microbix First Quarter Sales Grow Over 50% With Continued Progress On The Pipeline 4
(Date:12/4/2009)... model of heart cells, University of Iowa investigators have ... II (CaM kinase), disrupts the electrical activity of heart ... Columbia University, was published online Dec. 3 in the ... researchers have developed great interest in calmodulin kinase II ...
(Date:12/3/2009)... plant and animal species can be likened to emptying a ... potential medicines into the trash, or replacing every local cuisine ... their habitats may not just make the world boring. New ... risk for catching some nasty disease. , "Habitat destruction and ...
(Date:12/3/2009)... Rapids, Mich. (Dec. 3, 2009) Van Andel ... hormone abscisic acid (ABA) works at the molecular level to ... cold. Their findings, published in the journal Nature ... around the world and combat global food shortages. The ...
Breaking Biology News(10 mins):U-Iowa study helps advance heart-related research 2Species down, disease up 2Species down, disease up 3Species down, disease up 4VAI researchers find long awaited key to creating drought resistant crops 2VAI researchers find long awaited key to creating drought resistant crops 3More Swine Flu Vaccine Coming Soon 60183 1More Swine Flu Vaccine Coming Soon 60183 2More Swine Flu Vaccine Coming Soon 60183 3Section 1803 3A Senate Health Care Bill Makes Planned Parenthood Quasi Government Agency 3F Asks ALL 60180 1Section 1803 3A Senate Health Care Bill Makes Planned Parenthood Quasi Government Agency 3F Asks ALL 60180 21 800 Therapist Announces New Executive Team and Tele Therapy Offering 60177 11 800 Therapist Announces New Executive Team and Tele Therapy Offering 60177 2
... Rochelle, NY, July 8, 2008Biotech and pharmaceutical firms ... to streamline the complicated drug discovery process, reports ... GEN ). Most successful approaches rely on a ... advanced data-analysis tools, according to an article in ...
... at the Biodesign Institute at Arizona State University have made ... biologically engineered organism that can effectively deliver an antigen in ... to use live salmonella bacterium as the containment/delivery method for ... forward in development of a new means of biological containment ...
... suitable carrier for an oral vaccine against Alzheimer,s disease, ... of Bioscience and Biotechnology (KRIBB) in Korea and colleagues ... Science at Wonkwang University. Although their research (1), just ... is still in the early stages, it is a ...
Other Biology News:From foe to friend: Researchers use salmonella as a way to administer vaccines in the body 2From foe to friend: Researchers use salmonella as a way to administer vaccines in the body 3From foe to friend: Researchers use salmonella as a way to administer vaccines in the body 4Can tomatoes carry the cure for Alzheimer's? 2
... Glycine Transporter 2, Neuronal (GLYT2). The antiserum ... the central nervous system. The staining pattern ... described using in situ hybridization with probes ... been described for glycinergic neurons. Preabsorption of ...
Mouse monoclonal [RIZ1723] to PRDM2/RIZ...
... OA-Hy cis- 9-Octadecenoyl-N-hydroxylamide ... LIGHT. PACKAGED UNDER INERT GAS. A potent ... dose-dependent manner (K i = 1.7 ... Soluble in EtOH or DMSO. Unstable in ...
... Reacts with an early protein. ... 3 hours post-infection exhibiting an ... peak intensity between 6-24 hours. ... intense coarsely granular staining. ...
Biology Products: